BioCentury | Aug 18, 2014
Clinical News

Tirosint levothyroxine: Postmarketing study started

...Akrimax Pharmaceuticals LLC (Cranford, N.J.) began the open-label, U.S. postmarketing CONTROL trial to evaluate once-daily Tirosint...
...said Tirosint is the only levothyroxine therapy in a liquid gel cap. Institute Biochimique manufactures Tirosint...
...Akrimax, which distributes the product in the U.S. Institut Biochimique S.A. , Lugano, Switzerland Product: Tirosint...
BioCentury | Aug 27, 2007
Company News

Alpharma, Institut Biochimique S.A. sales and marketing update

...ALO received exclusive U.S. rights to distribute Institut Biochimique's Flector Patch and Tirosint levothyroxine. Institut Biochimique...
...NSAID to treat acute pain due to minor strains, sprains and contusions in early 2008. Tirosint...
BioCentury | Aug 6, 2007
Clinical News

Tirosint levothyroxine regulatory update

...FDA approved an NDA for Tirosint levothyroxine sodium capsules for replacement or supplemental therapy in congenital...
...in the management of thyrotripin-dependent well-differentiated thyroid cancer. Institut Biochimique SA , Lugano, Switzerland Product: Tirosint...
Items per page:
1 - 3 of 3